InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Doyle Ramona, Directeur Médical. Insider active across 1 companies, notably Recursion Pharmaceuticals, INC.. Aggregated, 9 filings have been recorded. The latest transaction was disclosed on 16 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
€4,519832 shares@ €5.43160.0002% mcap1.5% of flow
Class A Common Stock
SEC:0001209191-22-030255:0·
€20,3209,072 shares@ €2.23980.0009% mcap6.7% of flow
Class A Common Stock
SEC:0001209191-22-022310:0·
€34,65715,625 shares@ €2.2180.0016% mcap11.4% of flow
Class A Common Stock
SEC:0001209191-22-014405:0·
038,499 shares0
Class A Common Stock
SEC:0001209191-22-007915:0·
038,499 shares0
Class A Common Stock
SEC:0001209191-22-007915·
€34,74615,625 shares@ €2.22370.0016% mcap11.4% of flow
Class A Common Stock
SEC:0001209191-22-006598:0·
€34,74615,625 shares@ €2.223728.4% of flow
Class A Common Stock
SEC:0001209191-22-006598·
€87,56840,322 shares@ €2.171771.6% of flow
Class A Common Stock
SEC:0001209191-22-002062·
€87,56840,322 shares@ €2.17170.0041% mcap28.8% of flow
Class A Common Stock
SEC:0001209191-22-002062:0·
9 of 9 declarations
About Doyle Ramona
Ramona Doyle is the Chief Medical Officer at RECURSION PHARMACEUTICALS, INC. She is responsible for the medical direction of the company, overseeing clinical and research activities. Ramona plays a key role in developing strategies to create innovative treatments and ensure patient safety. Her medical expertise is essential in guiding the company's strategic decisions and research initiatives.
